NYMX Nymox Pharmaceutical Corp
Nymox Pharmaceutical Corp, along with its subsidiaries, is a biopharmaceutical corporation, engaged in research and development of drugs and diagnostic products for aging population. Its product portfolio consists of Nic alert and Tobac alert.
$0.46 -0.80 (-63.85%)
As of 05/23/2022 16:00:00 EST IEX book CBOE book
Security Information
Category1:
US EquityCategory2:
Common stocksCategory3:
Micro cap
GICS sector: Health Care
Industry: Biotechnology
Index country: Canada
Country of incorporation: Bahamas
IPO date: 02/11/2013
Outstanding shares: 90,279,794
Average volume: 327,111
Market cap: $113,752,540
Current dividend yield: 0.00%
All SEC filings:
SEC Edgar Online
Annual filings:
20-F
Sedol:
Valuation (See tab for details)
PE ratio: 0.00
PB ratio: 23.97
PS ratio: 0.00
Return on equity: 1,092.37%
Net income %: 0.00%